General Information of the Protein
Protein ID
PT01800
Protein Name
Cysteinyl leukotriene receptor 1
Secondarily
Protein Name
Cysteinyl leukotriene D4 receptor
G-protein coupled receptor HG55
HMTMF81
Gene Name
CYSLTR1
Secondarily
Gene Name
CYSLT1
Sequence
MDETGNLTVSSATCHDTIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLIKTYHKKSAFQVYMINLAVADLLCVCTLPLRVVYYVHKGIWLFGDFLCRLSTYALYVNLYCSIFFMTAMSFFRCIAIVFPVQNINLVTQKKARFVCVGIWIFVILTSSPFLMAKPQKDEKNNTKCFEPPQDNQTKNHVLVLHYVSLFVGFIIPFVIIIVCYTMIILTLLKKSMKKNLSSHKKAIGMIMVVTAAFLVSFMPYHIQRTIHLHFLHNETKPCDSVLRMQKSVVITLSLAASNCCFDPLLYFFSGGNFRKRLSTFRKHSLSSVTYVPRKKASLPEKGEEICKV
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Small molecule receptor (family A GPCR)
>
Lipid-like ligand receptor (family A GPCR)
>
Leukotriene receptor
Function
Receptor for cysteinyl leukotrienes mediating bronchoconstriction of individuals with and without asthma. Stimulation by LTD4 results in the contraction and proliferation of smooth muscle, edema, eosinophil migration and damage to the mucus layer in the lung. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTD4 >> LTE4 = LTC4 >> LTB4.
    Show/Hide
Uniprot ID
Primary ID:
Q9Y271

Secondarily ID:
B2R954
D3DTE4
Q5JS94
Q8IV19
    Show/Hide
Ensembl ID
ENSG00000173198
HGNC ID
HGNC:17451
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000026 , CHO-K1
Compound ID Compound Name Compound Formula
CP0408242
4-[1-(carboxymethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]butanoic acid
   Show/Hide
C34H34ClNO5
 1
1
IC50 = 0.22 nM
   TI
   LI
   LO
   TS
CP0382287
3-[1-(carboxymethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]propanoic acid
   Show/Hide
C33H32ClNO5
 1
1
IC50 = 0.32 nM
   TI
   LI
   LO
   TS
CP0448955
2-[1-(carboxymethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]acetic acid
   Show/Hide
C32H30ClNO5
 1
1
IC50 = 0.47 nM
   TI
   LI
   LO
   TS
CP0418315
4-[1-(carboxymethyl)-7-[(E)-2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethenyl]-2-methylindol-3-yl]butanoic acid
   Show/Hide
C34H36ClNO5
 1
1
IC50 = 0.56 nM
   TI
   LI
   LO
   TS
CP0484535
4-[1-(carboxymethyl)-7-[(E)-2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C33H34ClNO5
 1
1
IC50 = 0.62 nM
   TI
   LI
   LO
   TS
CP0170068
(R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)glycine
   Show/Hide
C25H40N2O6S
 2
1
IC50 = 0.7 nM
   TI
   LI
   LO
   TS
2
Ki = 0.29 nM
   TI
   LI
   LO
   TS
CP0382290
4-[3-(2-carboxyethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-1-yl]butanoic acid
   Show/Hide
C35H36ClNO5
 1
1
IC50 = 0.79 nM
   TI
   LI
   LO
   TS
CP0382284
4-[1-(carboxymethyl)-2-methyl-7-[(E)-2-[4-[4-(2,3,4,5-tetrafluorophenyl)butoxy]phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C33H31F4NO5
 1
1
IC50 = 0.8 nM
   TI
   LI
   LO
   TS
CP0487602
4-[1-(carboxymethyl)-7-[(E)-2-[4-[4-(2,3,6-trifluorophenyl)butoxy]phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C32H30F3NO5
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0380609
4-[1-(3-carboxypropyl)-7-[2-[4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]butanoic acid
   Show/Hide
C36H38FNO5
 1
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS
CP0408236
4-[1-(carboxymethyl)-7-[(E)-2-[4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl]ethenyl]-2-methylindol-3-yl]butanoic acid
   Show/Hide
C34H36FNO5
 1
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS
CP0381577
4-[1-(3-carboxypropyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]butanoic acid
   Show/Hide
C36H38ClNO5
 1
1
IC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0408240
4-[1-(carboxymethyl)-7-[(E)-2-[4-(4-phenoxybutoxy)phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C32H33NO6
 1
1
IC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0411554
4-[1-(carboxymethyl)-2-methyl-7-[(E)-2-[4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C33H31F4NO5
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0427949
4-[1-(3-carboxypropyl)-4-fluoro-7-[2-[4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]butanoic acid
   Show/Hide
C36H37F2NO5
 1
1
IC50 = 1.7 nM
   TI
   LI
   LO
   TS
CP0566585
4-[1-(carboxymethyl)-2-methyl-7-[(E)-2-[4-[4-(2,3,5,6-tetrafluorophenyl)butoxy]phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C33H31F4NO5
 1
1
IC50 = 2.2 nM
   TI
   LI
   LO
   TS
CP0382282
4-[1-(carboxymethyl)-2-methyl-7-[(E)-2-[4-[4-(2,3,6-trifluorophenyl)butoxy]phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C33H32F3NO5
 1
1
IC50 = 2.4 nM
   TI
   LI
   LO
   TS
CP0494801
4-[1-(3-carboxypropyl)-2-methyl-7-[2-[4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl]ethynyl]indol-3-yl]butanoic acid
   Show/Hide
C35H33F4NO5
 1
1
IC50 = 2.8 nM
   TI
   LI
   LO
   TS
CP0484534
4-[1-(carboxymethyl)-7-[(E)-2-[4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C33H34FNO5
 1
1
IC50 = 2.9 nM
   TI
   LI
   LO
   TS
CP0428430
4-[1-(carboxymethyl)-7-[(E)-2-[4-[4-(3-chlorophenyl)butoxy]phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C32H32ClNO5
 1
1
IC50 = 3.1 nM
   TI
   LI
   LO
   TS
CP0382286
4-[1-(carboxymethyl)-7-[(E)-2-[4-(4-phenylbutoxy)phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C32H33NO5
 1
1
IC50 = 3.4 nM
   TI
   LI
   LO
   TS
CP0456062
4-[1-(3-carboxypropyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-4-fluoro-2-methylindol-3-yl]butanoic acid
   Show/Hide
C36H37ClFNO5
 1
1
IC50 = 3.4 nM
   TI
   LI
   LO
   TS
CP0428421
4-[1-(carboxymethyl)-2-methyl-7-[(E)-2-[4-(4-phenylbutoxy)phenyl]ethenyl]indol-3-yl]butanoic acid
   Show/Hide
C33H35NO5
 1
1
IC50 = 4.1 nM
   TI
   LI
   LO
   TS
CP0484537
4-[3-(carboxymethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-1-yl]butanoic acid
   Show/Hide
C34H34ClNO5
 1
1
IC50 = 5.5 nM
   TI
   LI
   LO
   TS
CP0432238
4-[1-(3-carboxypropyl)-4-fluoro-2-methyl-7-[2-[4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl]ethynyl]indol-3-yl]butanoic acid
   Show/Hide
C35H32F5NO5
 1
1
IC50 = 7.4 nM
   TI
   LI
   LO
   TS
CP0379267
4-(3-carboxypropyl)-8-[[4-(4-phenylbutoxy)benzoyl]amino]-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid
   Show/Hide
C30H32N2O7
 1
1
IC50 = 8.5 nM
   TI
   LI
   LO
   TS
CP0531079
3-[1-(2-carboxyethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]propanoic acid
   Show/Hide
C34H34ClNO5
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0408238
4-[1-(3-carboxypropyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-6-fluoro-2-methylindol-3-yl]butanoic acid
   Show/Hide
C36H37ClFNO5
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0382289
3-[3-(carboxymethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-1-yl]propanoic acid
   Show/Hide
C33H32ClNO5
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0408239
4-[3-(carboxymethyl)-4-[(E)-2-[4-(4-phenoxybutoxy)phenyl]ethenyl]indol-1-yl]butanoic acid
   Show/Hide
C32H33NO6
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0456063
4-[1-(3-carboxypropyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-5-fluoro-2-methylindol-3-yl]butanoic acid
   Show/Hide
C36H37ClFNO5
 1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0448956
4-[1-(2-carboxyethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]butanoic acid
   Show/Hide
C35H36ClNO5
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0448958
5-[3-(2-carboxyethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-1-yl]pentanoic acid
   Show/Hide
C36H38ClNO5
 1
1
IC50 = 25 nM
   TI
   LI
   LO
   TS
CP0484536
4-[1-(carboxymethyl)-7-[(E)-2-[4-[4-(2-methoxyphenyl)butoxy]phenyl]ethenyl]-2-methylindol-3-yl]butanoic acid
   Show/Hide
C34H37NO6
 1
1
IC50 = 46 nM
   TI
   LI
   LO
   TS
CP0382291
5-[3-(3-carboxypropyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-1-yl]pentanoic acid
   Show/Hide
C37H40ClNO5
 1
1
IC50 = 56 nM
   TI
   LI
   LO
   TS
CP0533704
5-[3-(carboxymethyl)-7-[2-[4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-1-yl]pentanoic acid
   Show/Hide
C35H36ClNO5
 1
1
IC50 = 65 nM
   TI
   LI
   LO
   TS
CP0379718
3-[(3-carboxycyclohexyl)carbamoyl]-4-[3-[4-(4-cyclohexyloxybutoxy)phenyl]propoxy]benzoic acid
   Show/Hide
C34H45NO8
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0037675
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
   Show/Hide
C35H36ClNO3S
 2
1 IC50 = 0.5 nM
2 IC50 = 2.3 nM
CP0045344
4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide
   Show/Hide
C31H33N3O6S
 1
1 IC50 = 1.9 nM
CP0145665
8-[4-(4-phenylbutyloxy)benzoyl]amino-2-(tetrazol-5-yl)-4-oxo-4H-1-benzopyran
   Show/Hide
C27H23N5O4
 1
1 IC50 = 4.3 nM
CP0170068
(R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)glycine
   Show/Hide
C25H40N2O6S
 2
1 IC50 = 7 nM
2 Ki = 0.6 nM
Clinical Information about the Protein
Target 1 ( Leukotriene CysLT1 receptor (CYSLTR1) )
Target Type Successful Target
Disease 1 Target-related Disease  1
1 Asthma [ICD-11: CA23]
Approved Drug(s) 4 Approved Drugs  4
1 Cinalukast Approved
Asthma
2 Montelukast Approved
Asthma
3 Pranlukast Approved
Asthma
4 Zafirlukast Approved
Asthma
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 Masilukast Phase 2
Asthma
Discontinued Drug(s) 6 Discontinued Drugs  6
1 Ablukast Discontinued in Phase 3
Asthma
2 RG-7152 Discontinued in Phase 1
Asthma
3 FPL-55712 Terminated
Asthma
4 ICI-198615 Terminated
Asthma
5 LM-1376 Terminated
Asthma
6 Tomelukast Terminated
Asthma